We investigated the pathologic significance of ductular reactions in chronic liver diseases with respect to cellular senescence. The expression of senescenceassociated
Ductular reaction (DR) is a reactive lesion at the portal tract interface comprising increased bile ductules with an accompanying complex of stromal and inflammatory cells. 1 From the standpoint of marker analysis, ductular cells in DR are reportedly heterogeneous in their phenotypes. [1] [2] [3] [4] [5] These markers include biliary antigens (cytokeratin [CK]7, CK19, and OV-6), hepatocyte antigens (HepPar1 and albumin), and other markers such as neural cell adhesion molecule (NCAM). [1] [2] [3] [4] [5] Recently, Zhou et al 6 studied lineages of "oval cells" present in DRs in cirrhotic livers using CK19, HepPar1 and NCAM, and they proposed cell lineage and marker relationships between bile ductular cells in DR. According to their model, bipotential stem cells are singly NCAM+, transition cells in bile ductular lineage are NCAM+ and CK19+, and transitional cells in the hepatocytic lineage are negative for all markers. 6 However, few studies comprehensively addressing the cell kinetics and direct evidence of proliferation of "bipotential stem/progenitor cells" and cellular senescence in DR are available in chronic liver diseases.
Recent progress disclosed that cellular senescence is involved in the pathophysiology of various liver diseases. [7] [8] [9] [10] [11] [12] [13] [14] [15] Cellular senescence is defined as a condition in which a cell no longer has the ability to proliferate. Senescent cells are irreversibly arrested at the G 1 phase of the cell cycle and do not respond to various external stimuli but remain metabolically active. Senescent cells display several characteristics such as shortened telomeres, increased expression of p16 INK4 and p21 WAF1/CIP , and increased activity of senescence-associated β-galactosidase. [16] [17] [18] Cellular senescence can be triggered by multiple mechanisms, including the epigenetic derepression of the INK4a/ARF locus and DNA Upon completion of this activity you will be able to:
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damage. 19 We have previously shown that at least a part of the ductular cells in DRs are at the state of cellular senescence in primary biliary cirrhosis (PBC), especially in the advanced stage. 11, 13 This finding raises the possibility that at least some type of DR may display cellular senescence rather than proliferation of the bipotential stem/progenitor cells proposed by Zhou et al. 6 In this study, we examined comprehensively the expression of proliferation and senescence markers to elucidate the phenotype of DR in representative chronic liver diseases such as PBC, chronic viral hepatitis (CVH), and nonalcoholic steatohepatitis (NASH). We discuss the significance of DR based on the findings in this study.
Materials and Methods

Classification of the Intrahepatic Biliary Tree
The intrahepatic biliary tree is classified into the intrahepatic large and small bile ducts (septal and interlobular bile ducts) by their size and distribution in the portal tracts. 20 In this study, septal and interlobular bile ducts are termed small bile ducts. Bile ductules are not included in the small bile ducts. Bile ductules are characterized by tubular or glandular structures with a poorly defined lumen and located at the periphery of the portal tracts and are not accompanied by parallel running hepatic arterial branches. 1, 20 Ductular cells in DR, 1 including intermediate hepatobiliary cells with a heterogeneous phenotype in the diseased liver, were also evaluated.
Liver Tissue Preparation
A total of 113 liver tissue specimens (all biopsied or surgically resected) were collected from the liver disease files of our laboratory and affiliated hospitals. The liver specimens included in this study were 37 PBC cases, 39 CVH cases, 25 NASH cases, and 12 "histologically normal" livers. All PBC cases were from patients fulfilling the clinical, serologic, and histologic characteristics consistent with a diagnosis of PBC. 21 PBC cases were staged histologically. 22 Of the PBC cases, 25 were stages 1 and 2 (early PBC) and 12 were stages 3 and 4 (advanced PBC). Of the CVH cases, 26 were regarded as fibrosis stages F0 to F2 and 13 as stages F3 and F4. 23 Of the 39 CVH cases, 3 were serologically positive for hepatitis B surface B antigen and 36 for anti-hepatitis C viral antibody. The grade of activity and stage in the NASH cases were assessed by using the criteria proposed by Brunt et al, 24 and 12 NASH cases were regarded as stages 1 and 2 and 13 as stages 3 and 4. Histologically normal livers were obtained from surgically resected livers for traumatic hepatic rupture or metastatic liver tumor. The liver tissues used were taken from the part sufficiently away from the trauma and tumor.
Liver tissue samples were fixed in 10% neutral buffered formalin and embedded in paraffin. More than 20 serial sections, 4-μm thick, were cut from each block. Several were processed routinely for histopathologic study, and the remainder were processed for immunohistochemical analysis. The Committee of Ethics, Kanazawa University, Kanazawa, Japan, approved this study.
Immunohistochemical Analysis
We examined immunohistochemically a cell proliferation marker (Ki-67 antigen), senescence-associated markers (p16 INK4a and p21 WAF1/Cip1 ), cell cycle markers (G 1 phase, cyclin D; S phase, cyclin A), CK7, NCAM, and HepPar1. Immunostaining was performed using the antibodies shown in ❚Table 1❚, as described previously. 12 In brief, after pretreatment for antigen retrieval as described in Table 1 and blocking endogenous peroxidase, the sections were incubated with the primary antibody at 4°C overnight. The EnVision+ solution (DAKO, Carpinteria, CA) was then applied for 30 minutes at room temperature. The reaction products were visualized using 3-3'-diaminobenizidine tetrahydrochloride (Sigma Chemical, St Louis, MO) and hydrogen peroxide. The sections were then lightly counterstained with methyl green or hematoxylin. A similar dilution of control mouse IgG (DAKO) was applied instead of the primary antibody as a negative control. Positive and negative control samples were routinely included.
Assessment of Immunostaining
All fields of each liver specimen were observed under a light microscope for the evaluation of immunohistochemical expression of CK7, NCAM, p16 INK4a , and p21 WAF1/Cip1 .
Extent of DRs
The extent of ductular cell proliferation was semiquantitatively assessed as follows: 1+, focal, more than 5 CK7+ ductules detected in one third or fewer portal tracts; or 2+, extensive, more than 5 CK7+ ductules detected in more than one third of portal tracts.
Extent of NCAM, p16 INK4a , and p21 WAF1/Cip1 Expression in DRs
The extent of expression was evaluated as follows: 1+, focal, positive cells detected in one third or fewer portal tracts; or 2+, extensive, positive cells detected in more than one third of portal tracts.
Ki-67 Labeling Index in DRs and Hepatocytes
The Ki-67 labeling index (LI) was regarded as a marker for cell proliferation activity. The Ki-67 LI was assessed in 5 or more portal tracts with more than 100 ductular cells in DRs and 5 representative foci composed of more than 100 hepatocytes in each specimen.
Double Immunostaining
We also performed double immunostaining for NCAM, CK7 with senescence markers (p16 INK4a and p21 WAF1/Cip1 ), and cell cycle markers (cyclin D and cyclin A) to characterize ductular cells in DRs in the selected sections, as described previously. 25 In brief, either of the senescence markers (p16 INK4a and p21 WAF1/Cip1 ) or cell cycle markers (cyclin D and cyclin A) was detected by first using the Vector Red Alkaline Phosphatase Substrate Kit I (Vector Laboratories, Burlingame, CA), followed by second staining for NCAM, CK7, or HepPar1 with the use of Alexa Fluor 488-labeled antimouse IgG (Molecular Probes, Eugene, OR). The Vector Red reaction product is highly fluorescent, with rhodamine excitation and emission filter systems. 25 The slides were then counterstained with 4'-6-diamidino-2-phenylindole (Molecular Probes) and coverslipped.
Statistical Analysis
Statistical analysis for the difference used the Wilcoxon rank sum test. The correlation coefficient of 2 factors was evaluated by using the Spearman rank correlation test. When the P value was less than .05, the difference was regarded as significant.
Results
Extent of CK7+ Ductular Cells in DR
Ductular cells in DR frequently expressed CK7 ❚Image 1❚ and ❚Image 2❚, and the extent of CK7+ ductular cells is shown in ❚Figure 1❚. The number of CK7+ ductular cells increased along with the progression of histologic stage in CVH and NASH (P < .05) and to a lesser degree in PBC. The number of CK7+ cells increased more in CVH and NASH at stages 1 and 2 and stages 3 and 4, respectively, than PBC at individual stages (P < .05). 
Expression of Senescence Markers
Expression of NCAM in Ductular Cells
Ductular cells expressed NCAM in the cell membrane to various degrees (Images 1 and 2). As shown in ❚Figure 3❚, the extent of NCAM expression in DRs was significantly increased in the advanced stage of PBC (1+, 33%; 2+, 67%) compared with the early stage of PBC (1+, 56%; 2+, 8%) and NASH (1+, 42%; 2+, 0%), CVH (1+, 62%; 2+, 4%), and normal livers (1+, 33%; 2+, 0%) (P < .05). The extent of NCAM expression in DRs was significantly increased in the advanced stage of NASH compared with the early stage of PBC, CVH, and NASH and normal livers (P < .05).
Characterization of DR Using Double Immunostaining
Cyclin D1 (G 1 phase marker) and cyclin A (S phase marker) were expressed in the nuclei of ductular cells. Double immunostaining showed that ductular cells positive for the senescence markers (p16 INK4a or p21 WAF1/Cip1 ) were always positive for cyclin D1 but negative for cyclin A. Double immunostaining showed that ductular cells expressing the senescence markers (p16 INK4a or p21 WAF1/Cip1 ) were always negative for Ki-67. Double immunostaining for CK7 and NCAM disclosed that many ductular cells coexpressed CK7 and NCAM in the advanced stage of PBC, whereas a part of the ductular cells coexpressed them in CVH and NASH at advanced stages ❚Image 3❚. Double immunostaining for the senescence markers (p16 INK4a and p21 WAF1/Cip1 ) and NCAM disclosed that the senescence markers were frequently coexpressed with NCAM-expressing ductular cells, especially in the advanced stage of PBC ❚Image 4❚. Most ductular cells expressing NCAM expressed cyclin D (G 1 phase marker), whereas few ductular cells expressed cyclin A ❚Image 5❚. This finding suggests that NCAM-expressing ductular cells are at senescence and the G 1 arrest state.
Cell Proliferative Activity (Ki-67 LI) in DR and Hepatocytes
Although Ki-67-labeled nuclei were scattered in hepatocytes (Ki-67 LI up to 5.6) and inflammatory cells in hepatic parenchyma, the Ki-67 LI was usually less than 1 in ductular cells in DRs ❚Image 6❚. In normal livers, the Ki-67 
Discussion
The data obtained in this study are summarized as follows: (1) A majority of ductular cells in DR expressed CK7, and the number of CK7+ ductular cells was increased in PBC, CVH, and NASH at their advanced histologic stages. (2) p16 INK4a and p21 WAF1/Cip1 were frequently expressed in ductular cells in PBC, CVH, and NASH at advanced stages, and a proportion of ductular cells expressing these molecules were particularly frequent in PBC at advanced stages. Ductular cells expressing p16 INK4a and p21 WAF1/Cip1 were always positive for cyclin D but negative for cyclin A. These cells also showed no K-67 labeling. (3) NCAM was usually coexpressed in ductular cells positive for p16 INK4a and p21 WAF1/Cip1 and was frequently expressed in PBC, CVH, and NASH at advanced histologic stages, particularly in PBC.
CK7 is a well-known marker of biliary cell lineage, 1,26 and it was found in this study that ductular cells in DR frequently expressed CK7 in any type of disease, and the number of CK7+ ductular cells increased along with the progression of histologic stage in PBC, CVH, and NASH. This finding is in accordance with previous studies, 26, 27 and DR could be directly or indirectly involved in the progression of these chronic liver diseases.
Cellular senescence, an irreversible cell growth arrest, is reportedly involved in the pathophysiology of various liver diseases, and senescent cells remain metabolically active. [7] [8] [9] [10] [11] [12] [13] [14] [15] Senescent cells display several biologic characteristics, and p16 INK4a and p21 WAF1/Cip1 are reported as cellular senescence to PBC than CVH in regard to expression of NCAM in a preliminary study. However, the expression of senescence markers was more frequent in the advanced stages of PBC than in extrahepatic bile duct obstruction. Therefore, other factors, for example, duration of disease, also seem to be related to this difference. Further studies are needed to clarify this important point. Double immunostaining showed that ductular cells positive for the senescence markers (p16 INK4a or p21 WAF1/ Cip1 ) were always positive for cyclin D1 (G 1 phase marker) but negative for cyclin A (S phase marker). Double immunostaining showed that ductular cells expressing the senescence markers (p16 INK4a or p21 WAF1/Cip1 ) were always negative for Ki-67. These data suggest that senescent bile ductules are actually arrested at the G 1 phase. Recent data suggest that senescent cells have an important role in modulating the microenvironment by secreting biologically active molecules such as cytokines (eg, interleukin [IL]-6 and IL-1), chemokines (eg, IL-8 and monocyte chemotactic protein [MCP]-1), growth factors, and profibrogenic factors. [28] [29] [30] In fact, studies in human beings with biliary disorders and in animal models of biliary fibrosis have shown that ductal epithelium can express a number of profibrogenic and chemotactic proteins (eg, IL-1, IL-6, IL-8, and MCP-1), with MCP-1 capable of markers. 16, 18 It was found in this study that p16 INK4a and p21 WAF1/Cip1 were frequently expressed in ductular cells in DRs in more than half of the PBC cases at the advanced stages compared with their early stages, in which fewer than 5% of PBC cases showed such overexpression of senescent markers in ductular cells. These findings reconfirmed our previous studies reporting the extensive expression of another senescence marker, senescence-associated β-galactosidase, in ductular cells in advanced stages of PBC. 11, 13 In addition, the expression of senescence markers (p16 INK4a and p21 WAF1/Cip ) was also significantly increased along with the stage of CVH and NASH. However, the proportion of ductular cells showing such senescence markers in DR was about one fourth and was lower in comparison with PBC at advanced stages. These findings suggest that cellular senescence develops gradually in ductular cells in DR along with the progression of histologic stages of PBC, CVH, and NASH, irrespective of the type of liver damage.
It is of interest that there was a difference between PBC and CVH in regard to senescence markers and NCAM expression. The difference between PBC and CVH may be based on the difference between DR in biliary disease and DR in hepatocellular disease because another biliary disease, acute extrahepatic bile duct obstruction, was more similar ❚Image 3❚ Immunostaining for cytokeratin (CK)7 (red) (left) and neural cell adhesion molecule (NCAM; green) (center) and both (right) in primary biliary cirrhosis (PBC), stage 4 (top) and in chronic viral hepatitis (CVH), A2F3, hepatitis C (bottom). Most of the ductular cells coexpress NCAM and CK7 in PBC, stage 4, whereas the coexpression of NCAM and CK7 is seen in a part of CK7+ bile ductular cells in CVH, A2F3 (moderate necroinflammatory activity, fibrosis) (arrow) (all parts, ×400). ❚Image 6❚ The expression of Ki-67 antigen (a cell proliferation marker) in primary biliary cirrhosis, stage 4. There are no Ki-67-labeled ductular cells (arrows), whereas there are several Ki-67-labeled hepatocytes (arrowheads) (×400). It is well known that a portion of "proliferating bile ductules" displays NCAM, 1, 36 and NCAM has been used as a marker of hepatic stem cells/progenitor cells (HSPCs) in several studies. 6, 37, 38 In a model of cell lineage and marker relationship between cells composing DRs, 6 bipotential stem cells were singly NCAM+, transition cells in the bile ductular lineage were NCAM+ and CK19+, and transitional cells in the hepatocellular lineage were negative for all markers. However, it was found in this study that NCAM-expressing ductular cells expressed features of cellular senescence and they failed to show active cell proliferation, particularly in PBC. In addition, most NCAM-expressing ductular cells expressed cyclin D (G 1 phase marker), and few NCAMexpressing ductular cells expressed cyclin A (S phase marker), raising a possibility that a majority of NCAMexpressing ductular cells are at a G 1 arrest state and failing to show the evidence of a real "proliferating" phase. Therefore, it seems likely that NCAM can be a marker of senescent ductular cells and that NCAM can have an autocrine or paracrine regulatory role in such a process of cellular senescence in bile ductules. The findings in the present study suggest that the term ductular reaction may be a more accurate term than proliferating bile ductules. However, the possibility that HSPCs are present among DRs could not be denied, and markers other than NCAM may be more suitable for the detection of HSPCs.
This study revealed that DRs are heterogeneous in cell kinetics and expression of NCAM and that at least a part of the ductular cells in DRs in PBC, CVH, and NASH are undergoing cellular senescence, and these senescent cells may be involved in the progression of these chronic liver diseases, particularly PBC. Our study raises a possibility that NCAM can be used as a marker of cellular senescence developing in DRs.
attracting and activating cells of inflammatory and stellate cell lineages. 31 Taken together, it is plausible that senescent ductular cells may secrete a part of these modulators in DRs and participate in regulating the microenvironment in DRs and possibly the fibrous progression of chronic liver diseases. Because the expression of senescence markers is greater in advanced disease than in early disease, it may be an alternative hypothesis that cellular senescence is a secondary phenomenon after the development of fibrosis, not a cause of fibrosis. However, a smaller number of senescent ductular cells was present even in the early stage of disease, and the increase of senescent ductular cells and the development of fibrosis may progress synergistically.
Evidence supporting a role for epithelial-mesenchymal transition (EMT) in repair of chronic liver injury is growing in human studies and animal model studies. [32] [33] [34] For example, cells in DR expressed epithelial (CK7, CK19, and E-cadherin) and mesenchymal markers (S100A4, vimentin, and matrix metalloproteinase-2) in human diseased livers. 32 The involvement of hedgehog signaling was reported in regulation of EMT during biliary fibrosis in rodents and humans. 33 NCAM is a mesenchymal phenotype, not an original epithelial phenotype; therefore, the increase of NCAMexpressing ductular cells demonstrated in this study may be related to EMT coexisting with cellular senescence. Yovchev et al 35 reported that epithelial cell adhesion molecule-positive and thymus cell antigen 1-positive (Thy-1+) cells represent 2 different populations of cells in the oval cell niche in rodent models. Epithelial cell adhesion molecule-positive oval cells are bipotential adult hepatic epithelial progenitors and display a mixed epithelial-mesenchymal phenotype. Thy-1+ cells are mesenchymal cells with characteristics of myofibroblasts/activated stellate cells. 35 Inflammatory and fibrogenic factors secreted by senescent ductular cells may regulate these Thy-1+ cells in the progression of fibrosis. Direct correlation between EMT and cellular senescence in DR remains to be elucidated.
NCAM is a cell surface adhesion molecule that has a role in morphogenesis, remodeling, and migration in several organs. 6, 36 Roskams et al 36 reported that a portion of proliferating bile ductules express NCAM, although the exact role or significance of NCAM+ bile ductules remains speculative. It was found in this study that the number of NCAM+ ductular cells was significantly increased in the advanced stages of PBC compared with early-stage PBC and with NASH and CVH in the advanced stages. Double immunostaining for CK7 and NCAM disclosed that many ductular cells coexpressed CK7 and NCAM in the advanced stages of PBC, whereas a part of the ductular cells coexpressed them in CVH and NASH in the advanced stages. Double immunostaining for the senescence markers (p16 INK4a and p21 WAF1/Cip1 ) and NCAM disclosed that the senescence markers were
